Loading clinical trials...
Loading clinical trials...
A Randomized, Double Blind, Placebo-controlled Parallel Study of Tolerability and Efficacy of Cannabidiol (CBD) on Motor Symptoms in Parkinson's Disease
Conditions
Interventions
Cannabidiol
Placebo
Locations
1
United States
University of Colorado hospital
Aurora, Colorado, United States
Start Date
September 5, 2018
Primary Completion Date
January 4, 2022
Completion Date
January 4, 2022
Last Updated
July 23, 2024
NCT07187843
NCT07543861
NCT07545473
NCT05748028
NCT07495462
NCT04876339
Lead Sponsor
University of Colorado, Denver
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions